Review articles related to beta-casein & milk protein

Milk Intolerance, Beta-Casein and Lactose
Pal S, Woodford K, Kukuljan S, Ho S, Nutrients. (2015). 7(9), 7285-97. External link 

Beta casein A1 and A2 in milk and human health. Report to New Zealand Food Safety Authority
Swinburn B, (2004). Prepared for New Zealand Food Safety Authority, July, 2004. External link

Scientific Report of EFSA prepared by a DATEX Working Group on the potential health impact of ß-casomorphins and related peptides
EFSA Scientific Report (2009). 231, 1-107. External link

The A2 milk case: a critical review
Truswell A.S, (2005). Eur J Cln Nutr. 59(5), 623-31. External link

A critique of Truswell’s A2 milk review
Woodford K.B, (2006). Eur J Clin Nutr. 60(3), 437-9. External link

Further research for consideration in ‘the A2 milk case’
Allison A.J, Clarke A.J, (2006). EurJ Clin Nutr. 60(7), 921-4. External link

Formation and Degradation of Beta-casomorphins in Dairy Processing
Nguyen D.D, Johnson S.K, Busetti F, Solah V.A, Crit Rev Food Sci Nutr. (2015). 55(14), 1955-67. External link 

Polymorphism of bovine beta-casein and its potential effect on human health
Kaminski S, Cieslinska A, Kostroyra E, (2007). J Appl Genet. 48(3), 189-98. External link

Health implications of milk containing beta-casein with the A2 genetic variant
Bell S.J, Grochoski G.T, Clarke A.J, (2006). Crit RevFood Sci Nutr. 46(1), 93-100. External link

Caseins as source of bioactive peptides
Silva S.V, Malcata F.X, (2005). International Dairy Journal (15): 1-15. External link

Functional Significance of Bioactive Peptides Derived from Milk Proteins
Kamauab S.M, Lua R, Chena W, Liua X, Tiana F, Shena Y, et al. (2010). Food Reviews International 26(4): 386-401. External link

Opioid peptides encrypted in intact milk protein sequences.
Meisel H & FitzGerald R.J, (2000). Br J Nutr. 84 Suppl 1, S27-31. External link

Opioid activities of beta-casomorphins
Brantl V, Teschemacher H, Blasig J, Henschen A, Lottspeich F, (1981). Life Sci. 28(17),1903-9. External link

Effects of milk-derived bioactives: an overview
Shah N.P, (2000). Br J Nutr. 84 Suppl 1:S3-10. External link

Immunoregulatory peptides in bovine milk
Gill H.S, Doull F, Rutherfurd K.J, Cross M.L, (2000). Br J Nutr. 84(Suppl 1), S111-7. External link

Heart Disease, Diabetes, Gut Immune Suppression and Epidemiology Studies
McLachlan C.N.S & Clarke A.J, (2002). Journal of Nutritional & Environmental Medicine, 12(3), 197-206. External link

Casein, a prohormone with an immunomodulating role for the newborn?
Migliore-Samour D & Jolles P, (1988). Experientia. 44(3), 188-93. External link

Casein-derived bioactive peptides: Biological effects, industrial uses, safety aspects and regulatory status.
Phelan M, Aherne A, FitzGerald R.J, O’Brien N.M, (2009). International Dairy Journal. 19, 643-54. External link

Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing
Gobbetti M, Stepaniak L, De Angelis M, Corsetti A, Di Cagno R, (2002). Crit Rev Food Sci Nutr. 42(3):223-39. External link

Beta-casein in cow’s milk: a major antigenic determinant for type 1 diabetes?
Pozzilli P, (1999). J Endocrinol Invest. 22(7), 562-7. External link

Milk A1 and A2 peptides and diabetes
Clemens R.A, (2011). Nestle Nutr Workshop Ser Pediatr Program. 67:187-95. External link

Intestinal assimilation of intact peptides and proteins from the diet–a neglected field?
Gardner M.L, (1984). Biol Rev Camb Philos Soc. 59(3):289-331. External link

Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia?
Lister J, Fletcher PJ, Nobrega JN, Remington G. Pharmacology, biochemistry, and behavior. (2015). 134:70-8. External link 

Gluten- and casein-free diets for autistic spectrum disorder (Review)
Millward C, Ferriter M, Calver S, Connell-Jones G, (2008). Cochrane Database Syst Rev. 16;(2):CD003498. External link

Reports on dietary intervention in autistic disorders
Knivsber A.M, Reichelt K.L, Nødland M, (2001). Nutritional neuroscience. 4(1):25-37. External link

Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention
Shattock P, Whiteley P, (2002). Expert Opin Ther Targets. 2002;6(2):175-83. External link

Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?
Reichelt K.L, Knivsberg A.M, (2003). Nutritional neuroscience. 6(1):19-28. External link

Opioid peptides and dipeptidyl peptidase in autism
Shattock P, Hooper M, Waring R, (2004). Dev Med Child Neurol. 46(5):357. External link

Gluten-Free and Casein-Free Diets in the Treatment of Autism Spectrum Disorders: A Systematic Review
Mulloy A, Lang R, O’Reilly M, Sigafoos J, Lancioni G, Rispoli M, (2010). Research in Autism Spectrum Disorders. 4(3):328-39. External link

Minireview. Peptides and the blood-brain barrier
Meisenberg G, Simmons W.H, (1983). Life Sci. 32(23):2611-23. External link

Saturable transport of peptides across the blood-brain barrier.
Banks, W. A & Kastin A. J, (1987). Life Sci. 41(11): 1319-38. External link

Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides
McLay R.N, Pan W, Kastin A.J, (2001). Peptides. 22(12):2181-255. External link

The role of respiratory failure caused by congenital central nervous system abnormalities and the effect of beta-casomorphins in sudden infant death syndrome pathogenesis
Suminska-Ziemann B, Gos T, Jankowski Z, (2015). Arch Med Sąd Kryminol. 65(2), 99-111. External link 

Sudden infant death syndrome and opioid peptides from milk.
Ramabadran K & Moore B.E, (1988). Am J Dis Child. 142(1):12-3. External link

Opioid peptides from milk as a possible cause of sudden infant death syndrome
Ramabadran K & Bansinath M, (1988). Med Hypotheses. 27(3):181-7. External link

Relation of beta-casomorphin to apnea in sudden infant death syndrome
Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M, (2003). Peptides. 24(6), 937-43. External link

Does milk increase mucus production?
Bartley J & McGlashan S.R, (2010). Med Hypotheses. 74(4):732-4. External link

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
Lambeir A.M, Durinx C, Scharpe S, De Meester I, (2003). Crit Rev Clin Lab Sci. 40(3):209-94. External link

Dipeptidyl-peptidase IV (CD26)–role in the inactivation of regulatory peptides
Mentlein R, (1999). Regul Pept. 85(1):9-24. External link

 

Back to Health Professionals
Back to top